SongYang(SH:603863) Tong Hua Shun Cai Bao·2025-04-29 10:07Financial Performance - The company reported a basic earnings per share of -1.15 yuan for 2024, showing a slight improvement of 0.86% compared to -1.16 yuan in 2023 [1] - The net profit for 2024 was -2.36 billion yuan, which is a marginal improvement from -2.37 billion yuan in 2023 [1] - The total revenue increased to 7.27 billion yuan in 2024, reflecting a growth of 9.32% from 6.65 billion yuan in 2023 [1] - The return on equity decreased to -41.35% in 2024, compared to -30.46% in 2023, indicating a worsening financial performance [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 75.15 million shares, accounting for 36.74% of the circulating shares, which is a decrease of 7.78 million shares from the previous period [2] - The largest shareholder, Wang Zhuangpeng, holds 42.73 million shares, representing 20.88% of the total share capital, with no change in holdings [3] - New entrants among the top shareholders include Shenzhen Nuclear Huaxi Medical Testing Laboratory, Yu Zhengrui, and Jin Deli, while notable exits include Wu Weibin and Hong Kong Central Clearing Limited [3] Dividend Policy - The company has announced no distribution or capital increase for the current period [2]